Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Staci, Horvath"'
Autor:
Rodney P. Rocconi, Laura Stanbery, Min Tang, Luciana Madeira da Silva, Adam Walter, Bradley J. Monk, Thomas J. Herzog, Robert L. Coleman, Luisa Manning, Gladice Wallraven, Staci Horvath, Ernest Bognar, Neil Senzer, Scott Brun, John Nemunaitis
Publikováno v:
Communications Medicine, Vol 2, Iss 1, Pp 1-9 (2022)
Abstract Background Broadened use of predictive molecular and phenotypic profiling amongst oncologists has facilitated optimal integration of targeted- and immuno-therapeutics into clinical care. However, the use of predictive immunomarkers in ovaria
Externí odkaz:
https://doaj.org/article/021ed7667e0a4a57b9255b4a5c98cf92
Autor:
Minal Barve, Phylicia Aaron, Luisa Manning, Ernest Bognar, Gladice Wallraven, Staci Horvath, Laura Stanbery, John Nemunaitis
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 16 (2022)
Background: Gemogenovatucel-T (Vigil) is a triple-function autologous tumor cell immunotherapy which expresses granulocyte-macrophage colony-stimulating factor and decreases expression of furin and downstream TGF-β1 and TGF-β2. Vigil has suggested
Externí odkaz:
https://doaj.org/article/b2dba5de4aa74292a27b20a8dde927db
Autor:
Rodney P. Rocconi, Laura Stanbery, Min Tang, Luciana Madeira da Silva, Adam Walter, Bradley J. Monk, Thomas J. Herzog, Robert L. Coleman, Luisa Manning, Gladice Wallraven, Staci Horvath, Ernest Bognar, Neil Senzer, Scott Brun, John Nemunaitis
Publikováno v:
Communications Medicine, Vol 3, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/3b116a0694f44c8587eec04fd9d3ea73
Autor:
Jonathan Oh, Minal Barve, Neil Senzer, Phylicia Aaron, Luisa Manning, Gladice Wallraven, Ernest Bognar, Laura Stanbery, Staci Horvath, Meghan Manley, John Nemunaitis, Adam Walter, Rodney P. Rocconi
Publikováno v:
Gynecologic Oncology Reports, Vol 36, Iss , Pp 100740- (2021)
Externí odkaz:
https://doaj.org/article/d3baaded57ca4fd4a1e40a9521b07521
Autor:
Peter Anderson, Maurizio Ghisoli, Brian D. Crompton, Kelly S. Klega, Leonard H. Wexler, Emily K. Slotkin, Laura Stanbery, Luisa Manning, Gladice Wallraven, Meghan Manley, Staci Horvath, Ernest Bognar, John Nemunaitis
Publikováno v:
Clinical Cancer Research. 29:1689-1697
Purpose: Treatment options for recurrent or refractory Ewing's sarcoma (ES) are limited. Vigil is a novel autologous tumor cell therapy expressing bi-shRNA furin/GMCSF plasmid, which previously demonstrated monotherapy activity in advanced ES. Herein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dabd853eb193c233f8a96470bdf13b21
https://doi.org/10.1158/1078-0432.ccr-22-2292
https://doi.org/10.1158/1078-0432.ccr-22-2292
Autor:
Johnathan Oh, Minal Barve, Neil Senzer, Phylicia Aaron, Luisa Manning, Gladice Wallraven, Ernest Bognar, Laura Stanbery, Staci Horvath, Meghan Manley, John Nemunaitis, Adam Walter, Rodney P. Rocconi
Publikováno v:
Gynecologic Oncology Reports, Vol 34, Iss , Pp 100648- (2020)
Externí odkaz:
https://doaj.org/article/e43f4809d0e54d0cba6c51742a18b756
Autor:
Vedin Barve, Ned Adams, Laura Stanbery, Luisa Manning, Staci Horvath, Gladice Wallraven, Ernest Bognar, Minal Barve, John Nemunaitis
Publikováno v:
Vaccines, Vol 9, Iss 10, p 1201 (2021)
Colorectal cancer is the third most diagnosed cancer in the United States. Five-year survival rates remain low and many patients will develop liver metastasis. Vigil is an immunotherapy manufactured from autologous tumor cells and transfected ex vivo
Externí odkaz:
https://doaj.org/article/a835ba1053e140a88aad329774d98a84
Autor:
Rodney P. Rocconi, Laura Stanbery, Luciana Madeira da Silva, Robert A. Barrington, Phylicia Aaron, Luisa Manning, Staci Horvath, Gladice Wallraven, Ernest Bognar, Adam Walter, John Nemunaitis
Publikováno v:
Vaccines, Vol 9, Iss 8, p 894 (2021)
Aim: To determine the relationship between gene expression profile (GEP) and overall survival (OS) by NanoString following treatment with Vigil. Patients and Methods: Recurrent ovarian cancer patients (n = 21) enrolled in prior clinical trials. Resul
Externí odkaz:
https://doaj.org/article/1ae2462f0f274e798495bd404584b2e1
Autor:
John Nemunaitis, Ernest Bognar, Staci Horvath, Meghan Manley, Gladice Wallraven, Luisa Manning, Laura Stanbery, Emily K. Slotkin, Leonard H. Wexler, Kelly S. Klega, Brian D. Crompton, Maurizio Ghisoli, Peter Anderson
Background:Treatment options for recurrent or refractory Ewing's sarcoma (ES) are limited. Vigil is a novel autologous tumor cell therapy expressing bi-shRNA furin/GMCSF plasmid, which previously demonstrated monotherapy activity in advanced ES. Here
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e9c17819c5c38aa589d9eacee45a4a2
https://doi.org/10.1158/1078-0432.c.6533209.v2
https://doi.org/10.1158/1078-0432.c.6533209.v2
Autor:
John Nemunaitis, Ernest Bognar, Staci Horvath, Meghan Manley, Gladice Wallraven, Luisa Manning, Laura Stanbery, Emily K. Slotkin, Leonard H. Wexler, Kelly S. Klega, Brian D. Crompton, Maurizio Ghisoli, Peter Anderson
supplementary table
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d446a4970956e0103abfff81aab4cc2
https://doi.org/10.1158/1078-0432.22490743.v1
https://doi.org/10.1158/1078-0432.22490743.v1